Aditxt and Copley Mutually Terminate Ignite Proteomics SPAC Business Combination
Aditxt and Copley Acquisition mutually terminated their SPAC business combination agreement for Ignite Proteomics, effective Oct. 9, 2026. No termination fees were incurred, and both parties will bear their own expenses. Aditxt will explore alternative strategic options. (ADTX)

